Reading Time: 2 minutesAbbVie, which this month walked away from a $55 billion deal to buy Dublin drugmaker Shire, on Friday reported quarterly revenue and earnings well above Wall Street expectations, fueled by soaring sales of its Humira arthritis drug. The Chicago drugmaker, which significantly boosted its full-year earnings forecast, said it earned $506 million, or 31 cents per share, in the third quarter. That compared with $964 million, or 60 cents per share, in the year-earlier period. Company sales rose 7.8 percent to $5.02 billion, topping the average analyst estimate of $4.83 billion, according to Thomson Reuters I/B/E/S. Excluding special items, AbbVie … Read more
- Andropause (183)
- Blog Testosterone (3)
- Diets (31)
- Drugs (9)
- Erectile Dysfunction (1)
- Fertility (7)
- HCG Injections (4)
- Hormone News (41)
- Hormone Therapy Review (54)
- How to Inject Hormones (2)
- HRT Fitness And Exercise (5)
- Human Growth Hormone (19)
- Human Growth Hormone Clinic (2)
- Hypogonadism (117)
- Hypopituitarism (2)
- Is it Low T (16)
- LabCorp Blood Testing Centers (1,809)
- Low Testosterone (242)
- Male Health (2)
- Male Sexual (3)
- Men's Health (15)
- Online Pharmacy (1)
- Quest Blood Testing Centers (1,325)
- Testosterone And Cancer (2)
- Testosterone Clinics (408)
- Testosterone Cream (37)
- Testosterone Cypionate (66)
- Testosterone Gel (96)
- Testosterone Information (1,278)
- Testosterone Injections (54)
- Testosterone News (34)
- Testosterone Replacement for Men (6)
- Testosterone Replacement Therapy (149)
- Testosterone Therapy (12)
- Omnitrope: How to Mix & Inject Omnitrope HGH Injections?
- Easily Increase Testosterone Levels and Improve Your Health Naturally: Just Follow These Tips!
- Norditropin Side Effects
- Choosing the Right Growth Hormone Therapy: A Comparison of Options
- Low T’ treatment appears to be safe for men with heart Disease.